Geode Capital Management, LLC Exagen Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Exagen Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 81,583 shares of XGN stock, worth $148,481. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,583

Previous 81,583 -0.0%

Holding current value

$148,481

Previous $162,000 20.37%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$2.24 - $2.93 $14,745 - $19,288	6,583 Added 8.78%	81,583 $197,000
Q4 2022 Feb 13, 2023	SELL	$2.1 - $3.4 $350 - $567	-167 Reduced 0.22%	75,000 $180,000
Q2 2022 Aug 12, 2022	SELL	$4.18 - $7.74 $327,431 - $606,297	-78,333 Reduced 51.03%	75,167 $431,000
Q1 2022 May 13, 2022	BUY	$7.12 - $11.06 $19,053 - $29,596	2,676 Added 1.77%	153,500 $1.23 Million
Q4 2021 Feb 11, 2022	SELL	$8.97 - $14.08 $84,048 - $131,929	-9,370 Reduced 5.85%	150,824 $1.75 Million

Q3 2021 Nov 12, 2021	BUY	$10.25 - $15.21 $219,801 - $326,163	21,444 Added 15.46%	160,194 $2.18 Million
Q2 2021 Aug 13, 2021	BUY	$12.4 - $17.92 $691,907 - $999,918	55,799 Added 67.27%	138,750 $2.08 Million
Q1 2021 May 12, 2021	BUY	$13.9 - $22.0 $66,706 - $105,578	4,799 Added 6.14%	82,951 $1.45 Million
Q4 2020 Feb 12, 2021	BUY	$11.19 - $16.05 $12,387 - $17,767	1,107 Added 1.44%	78,152 $1.03 Million
Q3 2020 Nov 13, 2020	SELL	$10.56 - $16.69 $19,356 - $30,592	-1,833 Reduced 2.32%	77,045 $835,000
Q2 2020 Aug 13, 2020	BUY	$11.0 - $16.7 $147,147 - $223,395	13,377 Added 20.42%	78,878 $978,000
Q1 2020 May 14, 2020	BUY	$12.7 - $25.95 $140,576 - $287,240	11,069 Added 20.34%	65,501 $1.04 Million
Q4 2019 Feb 13, 2020	BUY	$12.61 - $28.48 $686,387 - $1.55 Million	54,432 New	54,432 $1.38 Million

Others Institutions Holding XGN

# of Institutions

Shares Held

6.21M

Call Options Held

1.6K

Put Options Held

4.1K

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $29.6M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Exagen Inc. Transaction History